Journal article
Ensuring continued access to essential inhaled respiratory medications: a call to action from the Inhaled Respiratory medicine Innovation and environmental Sustainability (IRIS) group
- Abstract:
- The supply of pMDIs for our patients is about to be switched off. IRIS calls for greener next generation propellants (HFA-152a and HFO-1234ze) used in pMDIs to be excluded from the EU F-gas regulation and the proposed PFAS restriction. https://bit.ly/3OxQ2ry.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 501.2KB, Terms of use)
-
- Publisher copy:
- 10.1183/13993003.01873-2025
Authors
- Publisher:
- European Respiratory Society
- Journal:
- European Respiratory Journal More from this journal
- Volume:
- 67
- Issue:
- 6
- Pages:
- 2501873-2501873
- Publication date:
- 2026-06-04
- DOI:
- EISSN:
-
1399-3003
- ISSN:
-
0903-1936
- Language:
-
English
- Keywords:
- Pubs id:
-
2431982
- Local pid:
-
pubs:2431982
- Source identifiers:
-
W7163512425
- Deposit date:
-
2026-06-11
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- Other
If you are the owner of this record, you can report an update to it here: Report update to this record